Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.295 USD | -1.35% | -13.39% | +42.24% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.24% | 405M | |
-2.73% | 102B | |
+2.13% | 96.07B | |
-1.66% | 21.66B | |
-17.54% | 20.77B | |
-7.05% | 18.53B | |
-40.31% | 16.91B | |
-28.39% | 13.79B | |
-0.05% | 13.33B | |
+20.76% | 10.94B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Sector Update: Health Care Stocks Ending Near Tuesday Session Highs